Related references
Note: Only part of the references are listed.Acyclic Retinoid Inhibits Diethylnitrosamine-Induced Liver Tumorigenesis in Obese and Diabetic C57BLKS/J- +Lepr(db)/+Lepr(db) Mice
Masahito Shimizu et al.
CANCER PREVENTION RESEARCH (2011)
Inhibition of Intestinal Polyp Formation by Pitavastatin, a HMG-CoA Reductase Inhibitor
Naoya Teraoka et al.
CANCER PREVENTION RESEARCH (2011)
Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma
Diego F. Calvisi et al.
GASTROENTEROLOGY (2011)
Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice
Junpei Iwasa et al.
CANCER SCIENCE (2010)
Pitavastatin inhibits azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice
Yoichi Yasuda et al.
CANCER SCIENCE (2010)
Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
Eek Joong Park et al.
CELL (2010)
Adiponectin Modulates C-Jun N-Terminal Kinase and Mammalian Target of Rapamycin and Inhibits Hepatocellular Carcinoma
Neeraj K. Saxena et al.
GASTROENTEROLOGY (2010)
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Brad Q. Starley et al.
HEPATOLOGY (2010)
Insulin resistance raises the risk for recurrence of stage I hepatocellular carcinoma after curative radiofrequency ablation in hepatitis C virus-positive patients: A prospective, case series study
Kenji Imai et al.
HEPATOLOGY RESEARCH (2010)
Metabolic Syndrome and Hepatocellular Carcinoma Two Growing Epidemics With a Potential Link
Abby B. Siegel et al.
CANCER (2009)
Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diabetes
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2009)
Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Selected Practical Issues in Their Evaluation and Management
Raj Vuppalanchi et al.
HEPATOLOGY (2009)
Statins, Stem Cells, and Cancer
Kalamegam Gauthaman et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells
Chi-Hung Huang et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2009)
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
David B. Shackelford et al.
NATURE REVIEWS CANCER (2009)
Statins in liver disease: A molehill, an iceberg, or neither?
Curtis K. Argo et al.
HEPATOLOGY (2008)
Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia
Hideyuki Hyogo et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
A lipophilic statin, pitavastatin, suppresses inflammation-associated mouse colon carcinogenesis
Yumiko Yasui et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question
P. Loria et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2007)
Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model
Yoshihiro Kamada et al.
JOURNAL OF HEPATOLOGY (2007)
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
D. Grahame Hardie
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes:: A histopathological follow-up study
Mattlas Ekstedt et al.
JOURNAL OF HEPATOLOGY (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C
Giovanni Targher et al.
JOURNAL OF HEPATOLOGY (2007)
Adiponectin as an anti-inflammatory factor
Noriyuki Ouchi et al.
CLINICA CHIMICA ACTA (2007)
TNF-α alters visfatin and adiponectin levels in human fat
J. Hector et al.
HORMONE AND METABOLIC RESEARCH (2007)
Anti-inflammatory effect of pitavastatin on NF-κB activated by TNF-α in hepatocellular carcinoma cells
J Wang et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Cell cycle arrest and apoptosis induction in hepatocellular carcinoma cells by HMG-CoA reductase inhibitors.: Synergistic antiproliferative action with ligands of the peripheral benzodiazepine receptor
AP Sutter et al.
JOURNAL OF HEPATOLOGY (2005)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Steatosis: Co-factor in other liver diseases
EE Powell et al.
HEPATOLOGY (2005)
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
HB El-Serag et al.
GASTROENTEROLOGY (2004)
Statins augment collateral growth in response to ischemia but they do not promote cancer and atherosclerosis
M Sata et al.
HYPERTENSION (2004)
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
AM Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Pitavastatin ameliorates severe hepatic steatosis in aromatase-deficient (Ar-/-) mice
T Egawa et al.
LIPIDS (2003)
Anti-inflammatory agents inhibit the induction of leptin by tumor necrosis factor-α
BN Finck et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2002)
Share Paper
